We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$19M
2
SKX
Skechers
SKX
+$16.5M
3
SWTX
SpringWorks Therapeutics
SWTX
+$12.6M
4
WBA
Walgreens Boots Alliance
WBA
+$9.26M
5
DNB
Dun & Bradstreet
DNB
+$7.98M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$26.7M
2
FNA
Paragon 28, Inc.
FNA
+$18.3M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$18M
4
DFS
Discover Financial Services
DFS
+$16.7M
5
DESP
Despegar.com
DESP
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
151
Procter & Gamble
PG
$338B
$446K 0.07%
2,800
– –
CPB icon
152
Campbell Soup
CPB
$6.78B
$444K 0.07%
14,500
+4,300
+42% +$151K
HYAC
153
DELISTED
Haymaker Acquisition Corp 4
HYAC
$431K 0.07%
38,800
– –
ATEX icon
154
Anterix
ATEX
$1.81B
$419K 0.06%
+16,350
New +$478K
CHDN icon
155
Churchill Downs
CHDN
$6.18B
$404K 0.06%
4,000
– –
GT icon
156
Goodyear
GT
$1.75B
$402K 0.06%
38,800
– –
AQN icon
157
Algonquin Power & Utilities
AQN
$4.47B
$401K 0.06%
70,000
-15,000
-18% -$82.3K
SIRI icon
158
SiriusXM
SIRI
$9.61B
$401K 0.06%
17,454
– –
PRGO icon
159
Perrigo
PRGO
$1.78B
$401K 0.06%
15,000
– –
FTNT icon
160
Fortinet
FTNT
$119B
$370K 0.06%
3,500
– –
BAC.PRL icon
161
Bank of America Series L
BAC.PRL
$4B
$364K 0.06%
300
+25
+9% +$29.5K
JBLU icon
162
JetBlue
JBLU
$2.19B
$353K 0.05%
83,400
+20,000
+32% +$89.5K
CVGW
163
DELISTED
Calavo Growers
CVGW
$352K 0.05%
+13,250
New +$346K
TEF
164
DELISTED
Telefonica
TEF
$345K 0.05%
66,000
– –
KD icon
165
Kyndryl
KD
$2.91B
$340K 0.05%
8,100
– –
VOD icon
166
Vodafone
VOD
$36.7B
$336K 0.05%
31,500
– –
DELL icon
167
Dell
DELL
$285B
$331K 0.05%
2,700
– –
OLED icon
168
Universal Display
OLED
$4.32B
$331K 0.05%
2,140
– –
STT icon
169
State Street
STT
$51.4B
$330K 0.05%
3,100
– –
SHCO
170
DELISTED
Soho House & Co
SHCO
$329K 0.05%
44,750
– –
OPCH icon
171
Option Care Health
OPCH
$3.61B
$325K 0.05%
10,000
+4,000
+67% +$129K
ASML icon
172
ASML
ASML
$691B
$321K 0.05%
400
– –
GEV icon
173
GE Vernova
GEV
$269B
$317K 0.05%
+600
New +$250K
CEPT
174
DELISTED
Cantor Equity Partners II
CEPT
$313K 0.05%
+28,400
New +$321K
HXL icon
175
Hexcel
HXL
$7.6B
$311K 0.05%
5,500
+1,500
+38% +$79.3K
5 6
7
8 9

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.